查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1584734

抗過敏眼藥水市場：按類型、藥物類別、分銷管道、最終用戶分類 - 全球預測 2025-2030

Allergy Relieving Eye Drops Market by Type, Drug Class, Distribution Channel, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年抗過敏眼藥水市值為4.5016億美元，預計到2024年將達到4.8165億美元，複合年成長率為7.39%，預計到2030年將達到7.4159億美元。

過敏緩解眼藥水是專門用於緩解花粉、灰塵、寵物皮屑等過敏原引起的搔癢、發紅、流淚等症狀的特殊眼藥水。由於季節性過敏發生率的增加和環境污染的惡化導致眼睛不適加劇，對此的需求正在增加。這些眼藥水已應用於各種環境，從個人護理到臨床建議，以提供即時和長期緩解。最終用途範圍包括非處方藥和處方箋藥，為尋求緩解輕度至重度過敏反應症狀的廣大消費者提供服務。根據市場洞察，這一成長主要受到眼睛健康意識提高、全球過敏發生率增加以及容易出現眼睛相關問題的老年人口增加的影響。此外，配方創新，例如不含防腐劑的選擇和具有抗組織胺和發炎作用的雙效眼藥水，也是值得注意的潛在機會。鼓勵公司投資研發以提高產品效率並使其產品多樣化以贏得市場佔有率。然而，潛在的副作用、嚴格的監管要求以及消費者對整體非藥物治療方法的偏好等限制因素帶來了巨大的挑戰。此外，現有產品的飽和狀態以及影響消費者信心的產品召回案例可能會阻礙市場成長。潛在的創新領域包括開發個人化眼藥水，利用先進的診斷工具解決個人過敏原狀況，以及透過綜合解決方案監測和管理眼睛健康的數位健康。市場是動態的，並深受消費者意識和監管環境的影響，因此公司需要保持敏捷並專注於合規性和客戶參與，以推動成長。

主要市場統計
基準年[2023] 45016萬美元
預測年份 [2024] 4.8165 億美元
預測年份 [2030] 74159萬美元
複合年成長率（%） 7.39%

市場動態：快速發展的抗過敏眼藥水市場的關鍵市場洞察

供需的動態交互作用正在改變過敏緩解眼藥水市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 世界人口眼科疾病的盛行率
    • 政府關於及時眼科檢查和眼部衛生的舉措
    • 網路藥局廣泛提供抗過敏眼藥水
  • 市場限制因素
    • 滴眼技術的困難
  • 市場機會
    • 持續研發新型眼藥水
    • 新型抗過敏藥物介紹
  • 市場挑戰
    • 過敏眼藥水召回迅速增加

波特的五力：駕馭過敏緩解眼藥水市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解抗過敏眼藥水市場的外部影響

外部宏觀環境因素在塑造過敏緩解眼藥水市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解抗過敏眼藥水市場的競爭狀況

過敏緩解眼藥水市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV 定位矩陣過敏緩解眼藥水市場供應商的績效評估

FPNV 定位矩陣是評估過敏緩解眼藥水市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以繪製過敏緩解眼藥水市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對過敏緩解眼藥水市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地人群眼部過敏和疾病的盛行率
      • 政府關於及時眼科檢查和眼睛健康的舉措
      • 網路藥局提供多種過敏眼藥水
    • 抑制因素
      • 滴眼技術的困難
    • 機會
      • 持續研發引進新眼藥水的活性成分
      • 抗過敏藥物新技術介紹
    • 任務
      • 過敏眼藥水召回迅速增加
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章過敏緩解眼藥水市場：依類型

  • 特應性角結膜炎
  • 巨乳頭性結膜炎
  • 季節性和常年性過敏性結膜炎
  • 春卡他

第7章依藥物類別分類的抗過敏眼藥水市場

  • 抗組織胺藥
  • 減充血劑
  • 肥大細胞穩定劑
  • 非類固醇消炎劑
  • 血管收縮劑

第8章過敏緩解眼藥水市場：依通路

  • 醫院藥房
  • 網上銷售
  • 零售

第9章過敏緩解眼藥水市場：依最終用戶分類

  • 居家護理
  • 醫院/診所

第10章美洲抗過敏眼藥水市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區抗過敏眼藥水市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲抗過敏眼藥水市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Akorn, Inc.
  • Alcon Inc.
  • Amneal Pharmaceuticals, Inc.
  • Astellas Pharma Inc.
  • Bausch & Lomb Incorporated
  • Bausch Health Companies Inc.
  • CVS Health
  • Dr. Reddy's Laboratories Ltd.
  • Geri-Care Pharmaceuticals Corp.
  • Honeywell International Inc.
  • Johnson & Johnson services, Inc.
  • Lupin Pharmaceutical, Inc.
  • Mankind Pharma Ltd.
  • Mylan NV
  • Nicox SA
  • Novartis AG
  • Ocular Therapeutix, Inc.
  • OCuSOFT Inc.
  • Pfizer, Inc.
  • Prestige Consumer Healthcare Inc.
  • ROHTO Pharmaceutical Co., Ltd.
  • Santen Pharmaceutical Co., Ltd.
  • Similasan Corporation
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
  • Wockhardt
Product Code: MRR-456C7E866862

The Allergy Relieving Eye Drops Market was valued at USD 450.16 million in 2023, expected to reach USD 481.65 million in 2024, and is projected to grow at a CAGR of 7.39%, to USD 741.59 million by 2030.

Allergy-relieving eye drops are specialized ophthalmic solutions designed to alleviate symptoms like itching, redness, and watering caused by allergens such as pollen, dust, and pet dander. Their necessity is underscored by the increasing prevalence of seasonal allergies and escalating rates of pollution, which exacerbate ocular discomfort. These drops find applications in diverse settings, from personal care to clinical recommendations, serving both immediate and long-term relief purposes. The end-use scope encompasses both over-the-counter and prescription segments, catering to a broad range of consumers seeking symptomatic relief from mild to severe allergic reactions. Market insights reveal that growth is primarily influenced by heightened awareness of ocular health, increasing incidences of allergies globally, and the expanding geriatric demographic more prone to eye-related issues. Moreover, innovations in formulation, such as preservative-free options and dual-action drops that offer both antihistamine and anti-inflammatory benefits, are notable potential opportunities. Companies are advised to invest in research and development to enhance product efficacy and diversify offerings to capture market share. However, limitations such as possible side effects, stringent regulatory requirements, and consumer preference for holistic and non-pharmacological remedies present formidable challenges. Moreover, market growth could be hindered by the saturation of existing products and instances of product recalls impacting consumer trust. Potential areas for innovation include the development of personalized drops that cater to individual allergen profiles using advanced diagnostic tools, and leveraging digital health platforms for monitoring and managing eye health with integrated solutions. The market is dynamic, heavily influenced by consumer awareness and regulatory landscapes, indicating that businesses must be agile, focusing on compliance and customer engagement to drive growth.

KEY MARKET STATISTICS
Base Year [2023] USD 450.16 million
Estimated Year [2024] USD 481.65 million
Forecast Year [2030] USD 741.59 million
CAGR (%) 7.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Allergy Relieving Eye Drops Market

The Allergy Relieving Eye Drops Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of eye allergies and disorders among the population worldwide
    • Government initiatives regarding timely eye checkups and ophthalmic health
    • Wide availability of allergy eye drops through online pharmacies
  • Market Restraints
    • Difficulties associated with eye drop techniques
  • Market Opportunities
    • Ongoing R&D for introducing new eye drop actives
    • Introduction of new allergy relieving drug techniques
  • Market Challenges
    • Surging incidence of allergy eye drop recalls

Porter's Five Forces: A Strategic Tool for Navigating the Allergy Relieving Eye Drops Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Allergy Relieving Eye Drops Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Allergy Relieving Eye Drops Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Allergy Relieving Eye Drops Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Allergy Relieving Eye Drops Market

A detailed market share analysis in the Allergy Relieving Eye Drops Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Allergy Relieving Eye Drops Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Allergy Relieving Eye Drops Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Allergy Relieving Eye Drops Market

A strategic analysis of the Allergy Relieving Eye Drops Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Allergy Relieving Eye Drops Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Akorn, Inc., Alcon Inc., Amneal Pharmaceuticals, Inc., Astellas Pharma Inc., Bausch & Lomb Incorporated, Bausch Health Companies Inc., CVS Health, Dr. Reddy's Laboratories Ltd., Geri-Care Pharmaceuticals Corp., Honeywell International Inc., Johnson & Johnson services, Inc., Lupin Pharmaceutical, Inc., Mankind Pharma Ltd., Mylan N.V., Nicox SA, Novartis AG, Ocular Therapeutix, Inc., OCuSOFT Inc., Pfizer, Inc., Prestige Consumer Healthcare Inc., ROHTO Pharmaceutical Co., Ltd., Santen Pharmaceutical Co., Ltd., Similasan Corporation, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., and Wockhardt.

Market Segmentation & Coverage

This research report categorizes the Allergy Relieving Eye Drops Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Atopic Keratoconjunctivitis, Giant Papillary Conjunctivitis, Seasonal & Perennial Allergic Conjunctivitis, and Vernal Keratoconjunctivitis.
  • Based on Drug Class, market is studied across Antihistamines, Decongestant, Mast cell stabilizers, Non-Steroidal Anti-Inflammatory Drugs, and Vasoconstrictors.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Sales, and Retail.
  • Based on End-User, market is studied across Homecare and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of eye allergies and disorders among the population worldwide
      • 5.1.1.2. Government initiatives regarding timely eye checkups and ophthalmic health
      • 5.1.1.3. Wide availability of allergy eye drops through online pharmacies
    • 5.1.2. Restraints
      • 5.1.2.1. Difficulties associated with eye drop techniques
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing R&D for introducing new eye drop actives
      • 5.1.3.2. Introduction of new allergy relieving drug techniques
    • 5.1.4. Challenges
      • 5.1.4.1. Surging incidence of allergy eye drop recalls
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Allergy Relieving Eye Drops Market, by Type

  • 6.1. Introduction
  • 6.2. Atopic Keratoconjunctivitis
  • 6.3. Giant Papillary Conjunctivitis
  • 6.4. Seasonal & Perennial Allergic Conjunctivitis
  • 6.5. Vernal Keratoconjunctivitis

7. Allergy Relieving Eye Drops Market, by Drug Class

  • 7.1. Introduction
  • 7.2. Antihistamines
  • 7.3. Decongestant
  • 7.4. Mast cell stabilizers
  • 7.5. Non-Steroidal Anti-Inflammatory Drugs
  • 7.6. Vasoconstrictors

8. Allergy Relieving Eye Drops Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Sales
  • 8.4. Retail

9. Allergy Relieving Eye Drops Market, by End-User

  • 9.1. Introduction
  • 9.2. Homecare
  • 9.3. Hospitals & Clinics

10. Americas Allergy Relieving Eye Drops Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Allergy Relieving Eye Drops Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Allergy Relieving Eye Drops Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Akorn, Inc.
  • 3. Alcon Inc.
  • 4. Amneal Pharmaceuticals, Inc.
  • 5. Astellas Pharma Inc.
  • 6. Bausch & Lomb Incorporated
  • 7. Bausch Health Companies Inc.
  • 8. CVS Health
  • 9. Dr. Reddy's Laboratories Ltd.
  • 10. Geri-Care Pharmaceuticals Corp.
  • 11. Honeywell International Inc.
  • 12. Johnson & Johnson services, Inc.
  • 13. Lupin Pharmaceutical, Inc.
  • 14. Mankind Pharma Ltd.
  • 15. Mylan N.V.
  • 16. Nicox SA
  • 17. Novartis AG
  • 18. Ocular Therapeutix, Inc.
  • 19. OCuSOFT Inc.
  • 20. Pfizer, Inc.
  • 21. Prestige Consumer Healthcare Inc.
  • 22. ROHTO Pharmaceutical Co., Ltd.
  • 23. Santen Pharmaceutical Co., Ltd.
  • 24. Similasan Corporation
  • 25. Sun Pharmaceutical Industries Limited
  • 26. Teva Pharmaceutical Industries Ltd.
  • 27. Wockhardt

LIST OF FIGURES

  • FIGURE 1. ALLERGY RELIEVING EYE DROPS MARKET RESEARCH PROCESS
  • FIGURE 2. ALLERGY RELIEVING EYE DROPS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ALLERGY RELIEVING EYE DROPS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ALLERGY RELIEVING EYE DROPS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ALLERGY RELIEVING EYE DROPS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ALLERGY RELIEVING EYE DROPS MARKET DYNAMICS
  • TABLE 7. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY ATOPIC KERATOCONJUNCTIVITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY GIANT PAPILLARY CONJUNCTIVITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY SEASONAL & PERENNIAL ALLERGIC CONJUNCTIVITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY VERNAL KERATOCONJUNCTIVITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DECONGESTANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY MAST CELL STABILIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY VASOCONSTRICTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY RETAIL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM ALLERGY RELIEVING EYE DROPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. ALLERGY RELIEVING EYE DROPS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. ALLERGY RELIEVING EYE DROPS MARKET, FPNV POSITIONING MATRIX, 2023